Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lesogaberan in Chinese Patients With Refractory GERD
NCT02818309Phase 2Unknown
- Sponsor
- National Taiwan University Hospital
- Start
- Jan 2015
- Primary completion
- Nov 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of lesogaberan in gastroesophageal reflux disease (GERD), sponsored by National Taiwan University Hospital. Status: unknown.
02
Drugs
lesogaberan
03
Conditions
gastroesophageal reflux disease (GERD)
Beyond the preview
Go deeper on NCT02818309.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02818309.